Safety and effects of acetylated and butyrylated high‐amylose maize starch on youths recently diagnosed with type 1 diabetes: A pilot study
dc.contributor.author | Ismail, Heba M. | |
dc.contributor.author | Liu, Jianyun | |
dc.contributor.author | Netherland, Michael, Jr. | |
dc.contributor.author | Hasan, Nur A. | |
dc.contributor.author | Evans-Molina, Carmella | |
dc.contributor.author | DiMeglio, Linda A. | |
dc.contributor.department | Pediatrics, School of Medicine | |
dc.date.accessioned | 2025-03-03T09:07:14Z | |
dc.date.available | 2025-03-03T09:07:14Z | |
dc.date.issued | 2025 | |
dc.eprint.version | Final published version | |
dc.identifier.citation | Ismail HM, Liu J, Netherland M Jr, Hasan NA, Evans-Molina C, DiMeglio LA. Safety and effects of acetylated and butyrylated high-amylose maize starch on youths recently diagnosed with type 1 diabetes: A pilot study. Diabetes Obes Metab. 2025;27(2):987-992. doi:10.1111/dom.16039 | |
dc.identifier.uri | https://hdl.handle.net/1805/46150 | |
dc.language.iso | en_US | |
dc.publisher | Wiley | |
dc.relation.isversionof | 10.1111/dom.16039 | |
dc.relation.journal | Diabetes, Obesity & Metabolism | |
dc.rights | Attribution-NonCommercial 4.0 International | en |
dc.rights.uri | https://creativecommons.org/licenses/by-nc/4.0 | |
dc.source | PMC | |
dc.subject | C‐peptide levels | |
dc.subject | HAMS‐AB | |
dc.subject | SCFAs | |
dc.subject | Beta‐cell function | |
dc.subject | Dietary intervention | |
dc.subject | Glucose regulation | |
dc.subject | Glycaemic control | |
dc.subject | Metabolomics | |
dc.subject | Mixed‐meal tolerance test | |
dc.subject | Type 1 diabetes | |
dc.title | Safety and effects of acetylated and butyrylated high‐amylose maize starch on youths recently diagnosed with type 1 diabetes: A pilot study | |
dc.type | Article |